Product Code: BT 2226
"The increasing adoption of protein-based therapeutics is expected to drive the growth of the protein crystallization and crystallography market."
The global protein crystallization and crystallography market is estimated to grow from USD 1.1 billion in 2020 to USD 1.7 billion by 2025, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of this market include the increasing adoption of protein therapeutics, technological advancements in protein crystallization instruments and consumables, and the increasing focus on miniaturization.
"Consumables segment accounted for the largest share of the protein crystallization and crystallography market, by product and service, in 2019."
Based on product and service, the protein crystallization and crystallography market is segmented into consumables, instruments, and software and services. In 2019, the consumables segment accounted for the largest share of the protein crystallization and crystallography market. This can be attributed to the large number of reagent kits and microplates used in proteomics research. The consumables segment is further divided into reagents kits/screens, microplates, crystal mounts and loops, and other consumables. In 2019, the microplates segment accounted for the largest share of the protein crystallization and crystallography consumables market.
"Cryo-electron microscopy segment to grow at the highest CAGR in the protein crystallization and crystallography market during the forecast period"
Based on technology, the protein crystallization and crystallography market is segmented into X-ray crystallography, NMR spectroscopy, cryo-electron microscopy, and small-angle X-ray scattering (SAXS). The cryo-electron microscopy segment is projected to register the highest CAGR in the forecast period. Cryo-electron microscopy is an emerging technology where protein samples are studied at cryogenic temperatures (the temperature of liquid nitrogen). As these studies are carried out at cryogenic temperatures, they offer various advantages such as reduced thermal vibrations and greater resilience to X-rays, allowing the crystal to survive for longer durations in X-ray beams.
"Pharmaceutical companies are the largest end users of protein crystallization and crystallography products."
Based on end user, the protein crystallization and crystallography market is segmented into pharmaceutical companies, biotechnology companies, and research and government institutes. The pharmaceutical companies segment accounted for the largest share of the protein crystallization and crystallography market in 2019. This can be attributed to the increasing demand for protein-based drugs.
"The APAC market is expected to register the highest CAGR in the global protein crystallization and crystallography market during the forecast period"
The APAC market, particularly in China, Japan, and India, is expected to witness high growth in the coming five years. This growth will be driven by the emergence of a large number of research institutes, growing number of collaborations in China and India, and the rising demand for proteomics research in the region.
In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the protein crystallization and crystallography market.
Mentioned below is the breakdown of the interviews:
- By Respondent Type: Supply Side: 80% and Demand Side: 20%
- By Designation: C-level: 20%, D-level: 55%, and Others: 25%
- By Region: North America: 50%, Europe: 20%, APAC: 20%, and the RoW: 10%
The major players operating in the global protein crystallization and crystallography market include: Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).
Research Coverage:
The study covers the market across various segments. It aims at estimating the market size and the growth potential of this market across different segments (product and service, end user, technology, and region). The study also includes an in-depth competitive analysis of the key players operating in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
This report will help market leaders as well as new entrants in the market by providing information on the closest approximations of the revenue numbers for the overall depth filtration market and its subsegments. It will also help stakeholders to understand the competitive landscape, gain more insights to better position their businesses, and plan suitable go-to-market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 YEARS CONSIDERED FOR THE STUDY
- 1.4 CURRENCY
- 1.5 LIMITATIONS
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
- 2.2 MARKET DATA ESTIMATION & TRIANGULATION
- 2.2.1 DATA TRIANGULATION
- 2.2.2 MARKET ESTIMATION METHODOLOGY
- 2.3 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET OVERVIEW
- 4.2 ASIA PACIFIC: PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SHARE, BY END USER & COUNTRY (2019)
- 4.3 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY PRODUCT & SERVICE (2020-2025)
- 4.4 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY INSTRUMENTS MARKET SHARE, BY TYPE, 2020 VS. 2025
- 4.5 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION)
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 MARKET DRIVERS
- 5.2.1.1 Increasing demand for protein therapeutics
- 5.2.1.2 Technological advancements
- 5.2.1.3 Increasing focus on miniaturization
- 5.2.2 RESTRAINTS
- 5.2.2.1 High cost of instruments
- 5.2.3 OPPORTUNITIES
- 5.2.4 CHALLENGES
- 5.2.4.1 Dearth of skilled professionals
- 5.3 VALUE CHAIN ANALYSIS
- 5.3.1 RESEARCH
- 5.3.2 MANUFACTURING
- 5.3.3 MARKETING & SALES
- 5.4 TECHNOLOGY ANALYSIS
- 5.5 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET
6 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY
- 6.1 INTRODUCTION
- 6.2 X-RAY CRYSTALLOGRAPHY
- 6.2.1 NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO DRIVE MARKET GROWTH
- 6.3 NMR SPECTROSCOPY
- 6.3.1 NMR SPECTROSCOPY IS PREFERRED IN KINETIC AND DYNAMIC STUDIES
- 6.4 CRYO-ELECTRON MICROSCOPY
- 6.4.1 CRYO-ELECTRON MICROSCOPY SEGMENT TO WITNESS HIGH GROWTH IN THE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET
- 6.5 SMALL-ANGLE X-RAY SCATTERING (SAXS)
- 6.5.1 SAXS OFFERS VERY HIGH-RESOLUTION DIFFRACTION IMAGES
7 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY PRODUCT & SERVICE
- 7.1 INTRODUCTION
- 7.2 CONSUMABLES
- 7.2.1 MICROPLATES
- 7.2.1.1 96-well plates
- 7.2.1.1.1 96-well plates are commonly used in automated liquid handling systems
- 7.2.1.2 48-well plates
- 7.2.1.2.1 48-well plates are used for hanging drop vapor diffusion crystallization
- 7.2.1.3 24-well plates
- 7.2.1.3.1 24-well plates are commonly used in manual liquid handling systems in small laboratories
- 7.2.1.4 Other microplates
- 7.2.2 CRYSTAL MOUNTS & LOOPS
- 7.2.2.1 Crystal mounts and loops avoid cross-contamination and prevent damage to crystals
- 7.2.3 OTHER CONSUMABLES
- 7.3 REAGENT KITS/SCREENS
- 7.3.1 REAGENT KITS IMPROVE THE SENSITIVITY OF PROTEIN STRUCTURES
- 7.4 INSTRUMENTS
- 7.4.1 LIQUID HANDLING INSTRUMENTS
- 7.4.1.1 Automated liquid handling instruments
- 7.4.1.1.1 Rising preference for automated instruments to support market growth
- 7.4.1.2 Manual liquid handling instruments
- 7.4.1.2.1 Manual liquid handling instruments are commonly used in small laboratories
- 7.4.2 CRYSTAL IMAGING INSTRUMENTS
- 7.4.2.1 Crystal imaging instruments can differentiate between crystals of protein and salt
- 7.4.3 OTHER INSTRUMENTS
- 7.5 SOFTWARE & SERVICES
- 7.5.1 PROTEIN CRYSTALLIZATION SOFTWARE HELPS IN STREAMLINING THE ENTIRE WORKFLOW IN AUTOMATED LIQUID HANDLING INSTRUMENTS
8 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY END USER
- 8.1 INTRODUCTION
- 8.2 PHARMACEUTICAL COMPANIES
- 8.2.1 GROWING DEMAND FOR PROTEIN THERAPEUTICS TO DRIVE MARKET GROWTH
- 8.3 RESEARCH & GOVERNMENT INSTITUTES
- 8.3.1 GROWING RESEARCH ACTIVITIES BETWEEN ACADEMIC RESEARCH INSTITUTES & PROTEIN DRUG MANUFACTURERS TO SUPPORT MARKET GROWTH
- 8.4 BIOTECHNOLOGY COMPANIES
- 8.4.1 INCREASING PRESSURE ON BIOTECHNOLOGY COMPANIES TO DEVELOP NOVEL RECOMBINANT PROTEIN-BASED DRUGS WILL SUPPORT MARKET GROWTH
9 PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, BY REGION
- 9.1 INTRODUCTION
- 9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.1.1 Government funding for research related to proteins to drive market growth
- 9.2.2 CANADA
- 9.2.2.1 Increasing R&D activities in research institutes and universities to drive market growth
- 9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.1.1 Germany is the largest market for protein crystallization & crystallography in Europe
- 9.3.2 UK
- 9.3.2.1 Increasing R&D investments to support market growth
- 9.3.3 FRANCE
- 9.3.3.1 Regulatory hurdles and inadequate skilled workforce are expected to restrain market growth in France
- 9.3.4 REST OF EUROPE
- 9.4 ASIA PACIFIC
- 9.4.1 CHINA
- 9.4.1.1 Increasing research studies in China to propel market growth
- 9.4.2 JAPAN
- 9.4.2.1 Initiatives taken by the Japanese government to support market growth in Japan
- 9.4.3 INDIA
- 9.4.3.1 Growing pharma and biotech industries to propel market growth in India
- 9.4.4 REST OF ASIA PACIFIC (ROAPAC)
- 9.5 LATIN AMERICA
- 9.5.1 INCREASING RESEARCH IN VARIOUS DISEASE AREAS WILL PROPEL MARKET GROWTH IN LATIN AMERICA
- 9.6 MIDDLE EAST & AFRICA
- 9.6.1 INFRASTRUCTURE DEVELOPMENTS ARE SUPPORTING THE GROWTH OF THE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET IN THE REGION
10 COMPETITIVE LANDSCAPE
- 10.1 INTRODUCTION
- 10.2 MARKET RANKING ANALYSIS
- 10.3 MARKET EVALUATION FRAMEWORK
- 10.4 COMPETITIVE LEADERSHIP MAPPING
- 10.4.1 VISIONARY LEADERS
- 10.4.2 DYNAMIC DIFFERENTIATORS
- 10.4.3 INNOVATORS
- 10.4.4 EMERGING COMPANIES
- 10.5 COMPETITIVE SCENARIO
- 10.5.1 KEY PRODUCT LAUNCHES
- 10.5.2 KEY COLLABORATIONS
- 10.5.3 KEY ACQUISITIONS
- 10.5.4 KEY EXPANSIONS
11 COMPANY PROFILES
- 11.1 BRUKER CORPORATION (Business Overview, Products Offered, Recent Developments, and MNM View)*
- 11.2 RIGAKU CORPORATION
- 11.3 HAMPTON RESEARCH
- 11.4 AGILENT TECHNOLOGIES
- 11.5 CORNING INCORPORATED
- 11.6 TECAN GROUP
- 11.7 SAROMICS BIOSTRUCTURES
- 11.8 SPECTRIS PLC
- 11.9 CHARLES RIVER LABORATORIES
- 11.10 THERMO FISCHER SCIENTIFIC
- 11.11 CREATIVE BIOSTRUCTURE
- 11.12 ANTON PAAR GMBH
- 11.13 JENA BIOSCIENCE GMBH
- 11.14 MITEGEN
- 11.15 CALIBRE SCIENTIFIC, INC.
- 11.16 ARINAX SCIENTIFIC INSTRUMENTATION
- 11.17 FORMULATRIX
- 11.18 HELIX BIOSTRUCTURES, LLC
- 11.19 GREINER BIO-ONE INTERNATIONAL
- 11.20 DOUGLAS INSTRUMENTS LIMITED
- 11.21 ART ROBBINS INSTRUMENTS
Details on Business Overview, Products Offered, Recent Developments, and MNM View might not be captured in case of unlisted companies.
12 APPENDIX
- 12.1 DISCUSSION GUIDE
- 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 12.3 AVAILABLE CUSTOMIZATIONS
- 12.4 RELATED REPORTS
- 12.5 AUTHOR DETAILS
比較リスト
